U.S. market Closed. Opens in 16 hours 45 minutes

PSTX | Poseida Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue64.70M130.36M31.24KN/AN/AN/A2.98M
Cost of Revenue5.61M5.17M4.55M2.59M1.19MN/AN/A
Gross Profit59.09M125.19M-4.52M-2.59M-1.19MN/AN/A
Operating Expenses194.21M190.44M172.65K126.55K78.85M40.56M24.58M
Selling, General & Admin37.44M37.54M35.91K23.03K18.46M9.67M5.48M
Research & Development156.77M152.90M136.73K103.52K60.39M30.88M19.10M
Other Operating Expenses14.85M2.86M19.80K280.002.56M-821.00KN/A
Operating Income-129.50M-59.95M-141.41K-126.55K-85.53M-41.99M-19.67M
Other Expenses / Income6.18M-3.51M16.44K-3.23K-994.00K-2.25M-521.00K
Before Tax Income-123.32M-63.46M-124.97K-129.78K-86.53M-44.61M-20.19M
Income Tax Expenses-107.00K544.00K-4.53M-2.58M6.11M-202.00K-527.00K
Net Income-123.43M-64.00M4.40M2.45M-92.64M-44.40M-19.66M
Interest Expenses-8.67M6.37M3.36K3.51K3.55M1.80M558.00K
Basic Shares Outstanding90.19M71.91M62.18M36.00M39.73M35.93M39.73M
Diluted Shares Outstanding90.19M71.95M62.24M36.00M39.73M35.93M39.73M
EBITDA-129.50M-57.09M-121.62K-126.27K-75.10M-40.69M-18.95M
EBITDA Margin-200.15%-43.79%-389.32%0.00%0.00%0.00%-635.01%
EBIT-132.21M-57.09M-121.62K-126.27K-82.97M-42.81M-19.63M
EBIT Margin-204.33%-43.79%-389.32%0.00%0.00%0.00%-657.65%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙